Vincent Haguet

Dr. Vincent Haguet

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2017 in Frontiers in Oncology
Verified
Journal Article
Open access
FMFrédérique Mittler
Frédérique Mittler
POPatricia Obeïd
Patricia Obeïd
ARAnastasia V. Rulina
Anastasia V. Rulina
VHVincent Haguet
Vincent Haguet
XGXavier Gidrol
Xavier Gidrol
MBMaxim Y. Balakirev
Maxim Y. Balakirev
A recent decline in the discovery of novel medications challenges the widespread use of 2D monolayer cell assays in the drug discovery process. As a result, the need for more appropriate cellular models of human physiology and disease has renewed the interest in spheroid 3D culture as a pertinent model for drug screening. However, despite technological progress that has significantly simplified spheroid production and analysis, the seeming complexity of the 3D approach has delayed its adoption in many laboratories. The present report demonstrates that the use of a spheroid model may be straightforward and can provide information that is not directly available with a standard 2D approach. We describe a cost-efficient method that allows for the production of an array of uniform spheroids, their staining with vital dyes, real-time monitoring of drug effects, and an ATP-endpoint assay, all in the same 96-well U-bottom plate. To demonstrate the method performance, we analyzed the effect of the preclinical anticancer drug MLN4924 on spheroids formed by VCaP and LNCaP prostate cancer cells. The drug has different outcomes in these cell lines, varying from cell cycle arrest and protective dormancy to senescence and apoptosis. We demonstrate that by using high-content analysis of spheroid arrays, the effect of the drug can be described as a series of EC50 values that clearly dissect the cytostatic and cytotoxic drug actions. The method was further evaluated using four standard cancer chemotherapeutics with different mechanisms of action, and the effect of each drug is described as a unique multi-EC50 diagram. Once fully validated in a wider range of conditions, this method could be particularly valuable for phenotype-based drug discovery.

25 September 2006 in IEEE Transactions on Magnetics
Verified
Journal Article
Closed access
HCH. Chetouani
H. Chetouani
CJC. Jeandey
C. Jeandey
VHVincent Haguet
Vincent Haguet
HRH. Rostaing
H. Rostaing
CDC. Dieppedale
C. Dieppedale
GRG. Reyne
G. Reyne
Diamagnetic levitation was applied to micro-positioning and trapping of diamagnetic micron-sized particles and micro-droplets. Scale reduction laws for magnetism indicate that diamagnetism is highly efficient for magnetic MEMS. We demonstrate here that diamagnetic bodies can be contactless guided along magnetic grooves or trapped in magnetic wells both in air and in liquids. Levitation of water, ethanol and oil microdroplets was achieved within a 1.6 mm bore of a cylindrical magnet and in micromachined bulk magnets. Thick permanent micromagnets were also electroplated above silicon wafers in various matrix configurations. Diamagnetic levitation on micromagnet arrays was tested with 3 mum-large diamagnetic latex beads in a paramagnetic buffered solution. Trapping and arraying of microparticles in stable spatial levitation within magnetic wells were successfully achieved

1 August 2011 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
PKPaul Kauffmann
Paul Kauffmann
AIAmmara Ith
Ammara Ith
DODaniel O'BRien
Daniel O'BRien
VGVictor Gaude
Victor Gaude
FBFlorian Boué
Florian Boué
GRGilbert Reyne
Gilbert Reyne
Cell arrays are of foremost importance for many applications in pharmaceutical research or fundamental biology. Although arraying techniques have been widely investigated for adherent cells, organization of cells in suspension has been rarely considered. The arraying of non-adherent cells using the diamagnetic repulsive force is presented. A planar arrangement of Jurkat cells is achieved at the microscale above high quality microfabricated permanent magnets with remanent magnetization of Jr ≈ 1 T, in the presence of a paramagnetic contrast agent. The cytotoxicity of three Gd based contrast agents, Gd-DOTA, Gd-BOPTA and Gd-HP-DO3A, is studied. Among them, Gd-HP-DO3A appears to be the most biocompatible toward Jurkat cells. In close agreement with analytical simulations, diamagnetically ‘suspended’ cells have been successfully arrayed above square and honeycomb-like micromagnet arrays, which act as a “diamagnetophobic” surface. Living cell trapping is achieved in a simple manner using concentrations of Gd-HP-DO3A as low as 1.5 mM.

1 October 2009 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
XGXavier Gidrol
Xavier Gidrol
BFBrigitte Fouqué
Brigitte Fouqué
LGLamya Ghenim
Lamya Ghenim
VHVincent Haguet
Vincent Haguet
NPNathalie Picollet-D’hahan
Nathalie Picollet-D’hahan
BSBéatrice Schaack
Béatrice Schaack

16 February 2004 in Applied Physics Letters
Verified
Journal Article
Closed access
VHVincent Haguet
Vincent Haguet
DMD. Martin
D. Martin
LML. Marcon
L. Marcon
THT. Heim
T. Heim
DSD. Stiévenard
D. Stiévenard
OMOleg Melnyk
Oleg Melnyk
A concept for the electrical detection of a biological interaction is proposed, mainly based on the conductance variation of a nanometer size-gap (typically less than 100 nm) between two planar electrodes. A functionalized surface was used in the vicinity of the gap in order to concentrate the ligand/receptor complex between the electrodes. The chemistry chosen for the immobilization of the ligand on the biosensor surface is compatible with peptide structures. The receptor in solution was labeled with gold particles which can be inserted into the gap. A significant conductance variation was observed without having to use a silver enhancer solution in the case of biotin/streptavidin or biotin/antibiotin antibodies model ligand/receptor interactions.

12 February 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RBRicky Bhajun
Ricky Bhajun
Laurent GuyonLaurent Guyon
Laurent Guyon
APAmandine Pitaval
Amandine Pitaval
ESEric Sulpice
Eric Sulpice
SCStéphanie Combe
Stéphanie Combe
XGXavier Gidrol
Xavier Gidrol
MiRNAs are key regulators of gene expression. By binding to many genes, they create a complex network of gene co-regulation. Here, using a network-based approach, we identified miRNA hub groups by their close connections and common targets. In one cluster containing three miRNAs, miR-612, miR-661 and miR-940, the annotated functions of the co-regulated genes suggested a role in small GTPase signalling. Although the three members of this cluster targeted the same subset of predicted genes, we showed that their overexpression impacted cell fates differently. miR-661 demonstrated enhanced phosphorylation of myosin II and an increase in cell invasion, indicating a possible oncogenic miRNA. On the contrary, miR-612 and miR-940 inhibit phosphorylation of myosin II and cell invasion. Finally, expression profiling in human breast tissues showed that miR-940 was consistently downregulated in breast cancer tissues